PUREGON Inj Lös 300 IE für Pen Amp
Details
- Manufacturer
- MSD Merck Sharp & Dohme AG
- ATC code
- G03GA06
- Status
- 9 abgeschlossen
- Reported since
- 73 days
- First report
- 23.05.2016
- Active substance
- follitropinum beta
- Swissmedic no.
- 5545301
- Public price (PPUB)
- CHF 98.00
- Ex-factory price (PEXF)
- CHF 75.00
- Product information (AIPS)
- swissmedicinfo.ch →
Overview
PUREGON Inj Lös 300 IE für Pen Amp is a medication by MSD Merck Sharp & Dohme AG containing the active substance follitropinum beta (ATC code G03GA06). This entry is marked as resolved — the documented shortage lasted 73 days. Switzerland has 2 other products approved with the same active substance — none are currently available.
Available alternatives
No alternatives with the same active substance are currently available.
Composition
follitropinum beta 400 U.I., saccharum, natrii citras dihydricus, polysorbatum 20, methioninum, conserv.: alcohol benzylicus 4.8 mg, aqua ad iniectabile q.s. ad solutionem pro 0.480 ml.
Frequently asked questions
What can I do if PUREGON Inj Lös 300 IE für Pen Amp is unavailable?▾
Contact your pharmacy or treating physician. Substitution with a product containing the same active substance (follitropinum beta) is often possible. Available alternatives are listed above on this page.
What alternatives exist for PUREGON Inj Lös 300 IE für Pen Amp?▾
Available alternatives with the same active substance are listed above. follitropinum beta is the underlying active substance — pharmacies can dispense a generic or alternative brand after consulting with the doctor.
When will PUREGON Inj Lös 300 IE für Pen Amp be available again?▾
The expected delivery date — if communicated by the manufacturer — is shown in the detail section on this page. Shortages in this active-substance class typically last several weeks in Switzerland. Only the manufacturer can provide a binding forecast.
Why is PUREGON Inj Lös 300 IE für Pen Amp unavailable?▾
Common reasons include manufacturing problems, active-substance shortages, quality issues, or a planned withdrawal from the Swiss market. More detailed background — when disclosed by the manufacturer — is shown in the detail section above.
Where do I report a shortage of PUREGON Inj Lös 300 IE für Pen Amp?▾
Shortages are officially reported to drugshortage.ch (by manufacturers and pharmacies). Patients and treating physicians can escalate the shortage through their pharmacy — which has direct access to the reporting pipeline.
Source: drugshortage.ch · no warranty of completeness